A Study for Japanese Participants With Rheumatoid Arthritis (RA)

NCT01253226 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: LY2127399 (Tabalumab)
DRUG: Placebo

Sponsor

Eli Lilly and Company